Apomorphininjektionstherapie bei Morbus Parkinson

Research output: Contribution to journalReview article


Apomorphine as subcutaneous injections offers a valuable and effective treatment alternative for Parkinson patients with oral medication-resistant "off' phases. Its efficacy is stable during long-term therapy, with no signs of patient tolerance. Adverse events are usually mild. The best results are obtained with relatively young, active, and cognitively intact patients. Intermittent s.c. apomorphine therapy can improve the patients' possibilities to continue to work and to live a normal social life, by offering increased freedom and self-confidence through a reliable, quick rescue from the disabling medication-resistant off phases.


Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Neurology


  • apomorphine, injection, subcutaneous, Parkinson, dopamine agonist
Translated title of the contributionApomorphine Injection Therapy for Parkinson's Disease
Original languageGerman
Pages (from-to)S11-S16
JournalAktuelle Neurologie
Issue numberSuppl. 1
Publication statusPublished - 2011
Publication categoryResearch